X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Infectious Diseases

期刊標題檢索 INFECT DIS-NOR 最新評論: Concise and Clear Titles Reflecting the Core Content of the Article (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Infectious Diseases]您好,您是該頁面的第 29430 位訪客。

期刊簡介
期刊名稱Infectious Diseases Infectious Diseases
LetPub Score
5.2
50 ratings
Rate

Reputation
6.3

Influence
3.9

Speed
7.0

期刊簡稱INFECT DIS-NOR
ISSN2374-4235
E-ISSN2374-4243
h-index68
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.200.9540.796
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: General Immunology and Microbiology
Q111 / 61
Category: Immunology and Microbiology
Subcategory: Infectious Diseases
Q168 / 344
Category: Immunology and Microbiology
Subcategory: Microbiology (medical)
Q135 / 140

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Infectious Diseases (formerly Scandinavian Journal of Infectious Diseases) is a peer-reviewed journal publishing articles on all aspects of human infection, including pathogenesis, diagnosis, and treatment of infectious diseases, and also on medical microbiology and epidemiology
官方網站http://www.tandfonline.com/loi/infd20
在線稿件提交https://mc.manuscriptcentral.com/sinf
開放訪問No
出版商Taylor and Francis Ltd.
主題領域INFECTIOUS DISEASES
出版國/地區NORWAY
發行頻率
創刊年0
每年文章數98每年文章數趨勢
黃金OA百分比28.23%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
INFECTIOUS DISEASESSCIEQ130/132
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2374-4235%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 8 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Infectious Diseases】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640968
    BIOMATERIALS575515
    BIOMEDICINE & PHARMACOTHERAPY498369
    Frontiers in Pharmacology487368
    JOURNAL OF ETHNOPHARMACOLOGY479451
    Journal of Materials Chemistry B476067
    Frontiers in Immunology458033
    COLLOIDS AND SURFACES B-BIOINTERFACES419249
    COMPUTERS IN BIOLOGY AND MEDICINE416605
    Frontiers in Oncology413512
  •  

    Infectious Diseases Infectious Diseases
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Infectious Diseases] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:32:56 評論於
Concise and Clear Titles Reflecting the Core Content of the Article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:35:40 評論於
I believe that hard work and determination are the keys to success. No matter how talented someone may be, without putting in the effort and persevering through challenges, they will not achieve their goals. I have always lived by the motto "work hard, stay humble" and it has helped me reach my goals in life
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 21:54:16 評論於
What kind of titles do reviewers generally prefer?
(0) 讚! | 八坂篷蔚

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 14:32:24 評論於
What kind of title can impress reviewers?
(0) 讚! | 上清雨真

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Infectious Diseases] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*